Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study

Venous thromboembolism (VTE) is a common complication in newly diagnosed symptomatic multiple myeloma (NDMM) patients. We explored cellular and plasma hypercoagulability in NDMM patients to identify relevant biomarkers that can be used in combination with clinical factors in the development of a ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Fotiou, Despina, Sergentanis, Theodoros N., Papageorgiou, Loula, Stamatelopoulos, Kimon, Gavriatopoulou, Maria, Kastritis, Efstathios, Psaltopoulou, Theodora, Salta, Stella, Van Dreden, Patrick, Sangare, Rabiatou, Larsen, Annette K., Terpos, Evangelos, Elalamy, Ismail, Dimopoulos, Meletios A., Gerotziafas, Grigoris T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221885/
https://www.ncbi.nlm.nih.gov/pubmed/30405097
http://dx.doi.org/10.1038/s41408-018-0135-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221885/
https://www.ncbi.nlm.nih.gov/pubmed/30405097
http://dx.doi.org/10.1038/s41408-018-0135-y

Ejemplares similares